Caplan Jay David

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Caplan Jay David's trades of Fractyl Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
417.94
Quantity 28,638 -12.1%
Value US$1,401,492
Transaction date
Planned sale
Price
457.77
Quantity 46,657 +40.9%
Value US$1,204,474
Transaction date
Proposed sale
Price
62.55
Quantity 52,321
Value US$802,210
Transaction date
Sale
Price
2.47
Quantity 64,197 -29.5%
Value US$158,541
Transaction date
Sale
Price
2.90
Quantity 65,000 -68.1%
Value US$188,474
Transaction date
Proposed sale
Price
2.85
Quantity 65,000
Value US$185,213
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-03 2025-01-31
PlS Planned sale
28,638 -12.1%
417.94
US$1,401,492 		28,638 -12.1% 417.94 US$1,401,492
2025-02-03 2025-01-30
PlS Planned sale
46,657 +40.9%
457.77
US$1,204,474 		46,657 +40.9% 457.77 US$1,204,474
2025-01-30 2025-01-30
PrS Proposed sale
52,321
62.55
US$802,210 		52,321 62.55 US$802,210
2024-11-13 2024-11-11
S Sale
64,197 -29.5%
2.47
US$158,541 		64,197 -29.5% 2.47 US$158,541
2024-09-13 2024-09-12
S Sale
65,000 -68.1%
2.90
US$188,474 		65,000 -68.1% 2.90 US$188,474
2024-09-12 2024-09-12
PrS Proposed sale
65,000
2.85
US$185,213 		65,000 2.85 US$185,213